Kopiyawaththage U E Perera
Overview
Explore the profile of Kopiyawaththage U E Perera including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
3
Citations
15
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Derseh H, Perera K, Dewage S, Stent A, Koumoundouros E, Organ L, et al.
Front Pharmacol
. 2021 Nov;
12:700902.
PMID: 34744706
Idiopathic pulmonary fibrosis (IPF) is a progressive chronic lung disease characterized by excessive extracellular matrix (ECM) deposition in the parenchyma of the lung. Accompanying the fibrotic remodeling, dysregulated angiogenesis has...
2.
Derseh H, Dewage S, Perera K, Pagel C, Koumoundouros E, Organ L, et al.
Sci Rep
. 2019 Dec;
9(1):19893.
PMID: 31882807
Idiopathic pulmonary fibrosis (IPF) is a chronic progressive lung disease with limited therapeutic options and poor prognosis. IPF has been associated with aberrant vascular remodelling, however the role of vascular...
3.
Dewage S, Organ L, Koumoundouros E, Derseh H, Perera K, Samuel C, et al.
Exp Lung Res
. 2019 Nov;
45(9-10):310-322.
PMID: 31762329
Idiopathic pulmonary fibrosis (IPF) is a chronic progressive fibrotic lung disease with unknown cause. While the drugs nintedanib and pirfenidone have been approved for the treatment of IPF, they only...